Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1989 4
1991 4
1992 2
1993 1
1995 1
1996 3
1997 4
1998 3
1999 1
2000 3
2001 3
2002 2
2003 5
2004 1
2005 1
2006 2
2008 1
2011 1
2012 3
2013 6
2014 5
2015 6
2016 8
2017 4
2018 2
2019 2
2020 2
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders.
Herold KC, Gitelman SE, Ehlers MR, Gottlieb PA, Greenbaum CJ, Hagopian W, Boyle KD, Keyes-Elstein L, Aggarwal S, Phippard D, Sayre PH, McNamara J, Bluestone JA; AbATE Study Team. Herold KC, et al. Among authors: ehlers mr. Diabetes. 2013 Nov;62(11):3766-74. doi: 10.2337/db13-0345. Epub 2013 Jul 8. Diabetes. 2013. PMID: 23835333 Free PMC article. Clinical Trial.
Pacific biomarkers, inc.
Ehlers MR. Ehlers MR. Biomark Med. 2008 Jun;2(3):221-7. doi: 10.2217/17520363.2.3.221. Biomark Med. 2008. PMID: 20477411 Free article.
Targeting memory T cells in type 1 diabetes.
Ehlers MR, Rigby MR. Ehlers MR, et al. Curr Diab Rep. 2015 Nov;15(11):84. doi: 10.1007/s11892-015-0659-5. Curr Diab Rep. 2015. PMID: 26370695 Review.
81 results